1. Role: Department Vice-Chair. Scope: Department. Date: 2021.
Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG
Professor
Pharmacy Clinical & Admin Sci
Phone (405) 271-6878 x47296
Office O'Donoghue Research Bldg., 1122 NE 13th St., Ste. 4417, OKC 73117
Email jamie-miller@ouhsc.edu
Publications & Presentations
- 1. Johnson P N, Miller J L. Peer Review as a Professional Obligation: Steps and Tips to Becoming a High-Quality Reviewer. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2024; 29 : 570-577
2. Parman A, Miller J L, Neely S, Johnson P N, Gupta N. Rates of Stress Ulcer Prophylaxis Deprescribing in Children Receiving Usual versus High-Dose Corticosteroids in the Pediatric Intensive Care Unit with Status Asthmaticus. Hospital pharmacy. 2024; 59 : 677-683
3. Miller J L. Developmental Pharmacology, Pharmacokinetics, and Pharmacodynamics. ASHP. 2024
4. Miller J L. Neonatal Opioid Withdrawal Syndrome. ASHP. 2024
5. Patel K, Thomson S, Vijayan M, Makoni M, Johnson P N, Stephens K, Neely S, Miller J L. Vasopressin induced hyponatremia in infants <3 months of age in the neonatal intensive care unit. Frontiers in Pediatrics. 2024; 12 : 1-8
Grants
- 1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.
Awards and Honors
- 1. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2024.
2. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2024.
3. American Society of Health-System Pharmacists. Fellow of American Society of Health-System Pharmacists. Date: 2024.
4. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.
5. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.
Education
- 1. Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.
2. Degree: BS. Trevecca Nazarene University. Date: 2002.